Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;6(4):144-155.
doi: 10.1007/s40778-020-00178-y. Epub 2020 Aug 12.

The role of RNA epigenetic modification in normal and malignant hematopoiesis

Radovan Vasic  1   2   3 , Yimeng Gao  1   2 , Chengyang Liu  1   2 , Stephanie Halene  1   2
Affiliations

The role of RNA epigenetic modification in normal and malignant hematopoiesis

Radovan Vasic et al. Curr Stem Cell Rep. 2020 Dec.

Abstract

Purpose of review: RNA epigenetic modifications have been identified as novel, dynamic regulators of gene expression, with important impacts on stem cell fate decisions. Here we examine the functions of RNA modifications, with a focus on N 6-methyladenosine (m6A), in hematopoietic stem cells under normal conditions and in malignancy.

Recent findings: The m6A RNA modification is a critical regulator of hematopoiesis. Disruption of different elements of the m6A machinery can skew the balance of self-renewal and differentiation in normal hematopoietic stem cells. The m6A reader, writer, and eraser proteins are also overexpressed in myeloid leukemia, and disruption of their function impairs leukemogenesis. RNA m6A modification governs important aspects of immune system function, including immune cell development, immune signaling, and recognition of RNA as foreign or self. In hematopoietic stem cells, endogenously-derived double stranded RNA can form in the absence of m6A, inducing deleterious inflammatory pathways which compromise stem cell function.

Summary: The RNA modification m6A exerts a variety of functions in normal hematopoietic stem cells as well as leukemic cells. Pharmacologic modulation of different elements of the m6A machinery provides a promising avenue for ex vivo expansion of hematopoietic stem cells in the transplant setting, as well as for leukemia therapy.

Keywords: N6-methyladenosine; RNA modification; dsRNA; hematopoiesis; m6A.

PubMed Disclaimer

Conflict of interest statement

Compliance with Ethical Standards Radovan Vasic, Yimeng Gao, Chengyang Liu, and Stephanie Halene declare that they have no conflict of interest. Conflict of Interest The authors declare that they have no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Boccaletto P, Machnicka MA, Purta E, Piatkowski P, Baginski B, Wirecki TK, et al. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 2018;46(D1):D303–D3D7. doi: 10.1093/nar/gkx1030. - DOI - PMC - PubMed
    1. Roundtree IA, Evans ME, Pan T, He C. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187–1200. doi: 10.1016/j.cell.2017.05.045. - DOI - PMC - PubMed
    1. Perry RP, Kelley DE. Existence of methylated messenger RNA in mouse L cells. Cell. 1974;1(1):37–42. doi: 10.1016/0092-8674(74)90153-6. - DOI
    1. Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A. 1974;71(10):3971–3975. doi: 10.1073/pnas.71.10.3971. - DOI - PMC - PubMed
    1. Adams JM, Cory S. Modified nucleosides and bizarre 5′-termini in mouse myeloma mRNA. Nature. 1975;255(5503):28–33. doi: 10.1038/255028a0. - DOI - PubMed

LinkOut - more resources